QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS ; RAISES REVENUE AND EPS GUIDANCE FOR FULL YEAR 2026

What happened: Quest Diagnostics (NYSE: DGX) reported third quarter 2026 results with revenues of $3.10 billion and raised its full year 2026 revenue and EPS guidance. Key numbers: Q3 revenues $3.10 billion, up 10.0%. Reported diluted EPS $2.78, up 28.7%. Adjusted diluted EPS $3.00, up 15.4%. Full year 2026 revenue guidance $12.065 billion to $12.105 billion. Why it matters: CEO Jim Davis cited strength across physician, hospital and consumer channels plus productivity gains from automation and AI, and said the company is raising guidance on these growth trends and strong performance. Coverage: 4 outlets in 24h

Quest Diagnostics (NYSE: DGX) reported third quarter 2026 results with revenues of $3.10 billion and raised its full year 2026 revenue and EPS guidance.

CEO Jim Davis cited strength across physician, hospital and consumer channels plus productivity gains from automation and AI, and said the company is raising guidance on these growth trends and strong performance.